OCGN earnings call for the period ending June 30, 2023.
These companies haven't given up on the coronavirus vaccine market.
OCGN earnings call for the period ending March 31, 2023.
Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals...
The company is clearly progressing on several fronts with its pipeline programs.
OCGN earnings call for the period ending December 31, 2022.
They skyrocketed before. It could happen again.
Ocugen has recently broadened its pipeline.
Two of these stocks have what it takes to rebound and deliver lasting gains.